top of page

We have taken PCR to a whole new level. Our Hyperplex PCR™ technology enables detection of up to 100 markers in a single well with highly specific and ultra-sensitive performance.

dots-lightgrey-RGB.png

Efficiency

PCR has long been the go-to molecular testing method providing scalability and highly sensitive results. However, it may become impractical or costly for high-throughput projects where broad genomic insight is required, or when there is a need to detect difficult, numerous target sequences in a single sample.

or Performance

In comparison, NGS approaches excel in discovering novel genes and provide extreme sequence specificity. Yet, the initial equipment costs, ongoing reagent expenses, service fees, training required and turnaround time to results present significant barriers for many labs.​

Today, analysis needs compromise

dots-darkgrey-RGB.png

We bring you the future

Efficiency & Performance

To overcome these challenges, there is a need for new, accurate molecular testing solutions that can detect multiple, difficult and low abundance markers while simultaneously handle large sample volumes and seamlessly integrate into existing lab workflows without the need for substantial equipment investment.

dots-gradient-RGB.png
Introducing

An end-point quantitative PCR technology powered by padlock probes and RCA-based molecular counting ensuring single-nucleotide resolution and ultra-sensitivity together with hyperplex capabilities to detect 100+ targets in each well.

Analysis without compromise

Wider view

Detect up to 100 targets in a single sample


Deeper understanding

Highly specific and ultra-sensitive


Faster answers

Results within 4 hours


Seamless integration

Works with standard equipment and consumables

Powered by Nanopixels™ and Padlock-probes
Specs
How we compare to other technologies

Deeper, Wider, Faster

Challenges
We Are Solving

  • Labs increasingly need to detect a high number of targets from a single sample
    Our Benefit: hpPCR enables ultra-sensitive detection of 100+ targets in a single sample
  • qPCR/dPCR lacks specificity for difficult targets, requiring lenghty validation of new probes
    Our Benefit: hpPCR provides NGS-grade specificity for virtually any sequence and fast turnoround from probe design to implementation
  • NGS requires high investment in new equipment and significant training
    Our Benefit: hpPCR can be adopted within existing routine workflows, without the need for investment in complex or costly instrumentation by using existing thermocyclers and fluorescence readers. Talk with our team to find out how well your equipment already works.
  • NGS results take days or weeks
    Our Benefit: hpPCR can deliver results in as fast as 4 hours

Latest from
APLEX Bio

Meet Aplex Bio at CES2024

11 dec. 2023

Aplex Bio receives SEK 240,000 funding from Vinnova

2 nov. 2023

Aplex Bio selected as Deep Tech Pioneer by Hello Tomorrow

5 dec. 2023

Supported by

Partner_Scilife_white.png
Partner_EIT_white.png
Partner_KIAB_white.png
Partner_Vinnova
bottom of page